CiBB evaluated as Excellent in FCT R&D Unit evaluation
CEISUC welcomes the Excellent rating of the CiBB (Center for Innovative Biomedicine and Biotechnology)
16 april, 2025≈ 2 min read
The Centre for Innovative Biomedicine and Biotechnology (CiBB) has been awarded the highest classification of “Excellent” in the most recent evaluation of R&D Units by the Foundation for Science and Technology (FCT), under the 2023/2024 Multiannual Funding Program – see the provisional results here.
More information here.
Recent articles
CiBB evaluated as Excellent in FCT R&D Unit evaluation
User satisfaction with health services and healthcare delivery in Cape Verde
Porphyromonas Gingivalis and Fusobacterium nucleatum in oral Oncogenesis and Tumour Progression
Amelogenin-Based Molecular Methods for Sexual Dimorphism Identification: Protocol of a Scoping Review